Quality Target Product Profile (QTPP)

Quality Target Product Profile (QTPP) designates a prospective summary of quality characteristics ensuring desired product performance, forming the foundation for Quality by Design development approaches as outlined in ICH Q8 guidance. This systematic description defines drug product quality attributes considering route of administration, dosage form, delivery system, dosage strength, pharmacokinetic characteristics, drug release, stability, and container closure system establishing development targets derived from clinical and regulatory requirements.

The biopharmaceutical industry establishes QTPP early in development, guiding formulation design, process development, and control strategy establishment. QTPP elements typically address intended use and therapeutic objectives, dosage form and route of administration, dosage design and strength, container closure system, drug release characteristics ensuring appropriate pharmacokinetics, and stability under anticipated storage conditions. Development connects QTPP elements to critical quality attributes through risk assessment identifying which product characteristics directly impact clinical performance. Regulatory discussions employ QTPP communicating development strategy and product quality expectations. Process development translates QTPP into manufacturing capabilities establishing design space and control strategy. Benefits include systematic development focused on critical attributes, enhanced regulatory communication, and proactive quality by design. As QbD adoption increases and products become more complex, QTPP continues as foundational tool linking clinical requirements with product quality attributes.